Affinity DataKi: 0.0100nMAssay Description:Binding affinity to human integrin alphaVbeta6 assessed as dissociation constant up to 48 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 0.0200nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0251nMAssay Description:Binding affinity to human integrin alphaVbeta6 assessed as dissociation constant up to 48 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 0.0316nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0398nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0398nMAssay Description:Inhibition of integrin alphavbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0398nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0398nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0398nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0501nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0631nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0631nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0631nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0631nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0794nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0794nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0794nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.100nMAssay Description:Binding affinity to alphaVbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.107nMAssay Description:Inhibition of integrin alphavbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.174nMAssay Description:Inhibition of integrin alphavbeta6 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 1nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
Affinity DataKi: <1nMAssay Description:Displacement of [3H]UR-3189 from integrin alpha2b beta3 receptor in resting human plateletMore data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 1.30nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 1.30nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 1.30nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 1.60nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 1.60nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-1(Homo sapiens (Human))
Glaxosmithkline Medicines Research Centre
Curated by ChEMBL
Glaxosmithkline Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 2nMAssay Description:Inhibition of integrin alphavbeta1 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Binding affinity to human integrin alphaVbeta6 assessed as dissociation constant up to 48 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 2.5nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
Affinity DataKi: 2.5nMAssay Description:The compound was tested for binding affinity against Tachykinin receptor 2 from guinea pig tracheaMore data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 4nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 4nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 5nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 6.30nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 6.30nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Homo sapiens (Human))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 7.90nMAssay Description:The compound was tested for binding affinity against Tachykinin receptor 2 from human expressed in CHO cellsMore data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 7.90nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 10nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 10nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 10nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Glaxosmithkline Medicines Research Centre
Curated by ChEMBL
Glaxosmithkline Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 10nMAssay Description:Inhibition of integrin alphavbeta5 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 13nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 16nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 20nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 20nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 20nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Glaxosmithkline Medicines Research Centre
Curated by ChEMBL
Glaxosmithkline Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 40nMAssay Description:Inhibition of integrin alphavbeta3 (unknown origin) by radioligand binding assayMore data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 79nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:Binding affinity against tachykinin receptor 2 from rat colon.More data for this Ligand-Target Pair